Subscribe to Newsletter

Content by Stephanie Vine:

Manufacture Small Molecules

Leading the Charge

| Stephanie Vine

The world is making progress against COVID-19 – and small molecules are on the frontlines.

Business & Regulation Business Practice

When the Worst Happens

| Stephanie Vine

Business insurance exists to help companies when unexpected events and damages occur – so you need to have the right policy in place.

Business & Regulation

New Guidelines for Controlling Impurities

| Stephanie Vine

EMA reviews lessons learned from nitrosamine impurities.

Discovery & Development COVID-19

The COVID-19 Curator

| Stephanie Vine

Your roundup of the key scientific studies and industry announcements emerging from the pandemic.

Business & Regulation Business Practice

Access Not Denied

| Stephanie Vine

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.

Discovery & Development Drug Discovery

Going with Your Gut Instinct

| Stephanie Vine

Sitting Down With… Paul Peter Tak, President and CEO at Kintai Therapeutics.

Manufacture Bioprocessing - Upstream & Downstream

Editing for Purity

| Stephanie Vine

Secretome engineering eliminates unwanted proteins in CHO-based bioprocessing.

Business & Regulation Trends & Forecasts

The Counterfeit COVID-19 Crisis

| Stephanie Vine

How fakers are taking advantage of the pandemic.

Discovery & Development Drug Discovery

Data Finders

| Stephanie Vine

How can artificial intelligence and deep-learning platforms be used to combat malaria?

Discovery & Development Drug Discovery

Back to Immunity

| Stephanie Vine

Can we reverse the effect of the ageing process on the immune system?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register